Dr. Mifugi Urges GLP-1 Plans With 2-3 Weekly Workouts After 15%-21% Weight Loss Results
Updated
Updated · Rio Grande Guardian · Jun 15
Dr. Mifugi Urges GLP-1 Plans With 2-3 Weekly Workouts After 15%-21% Weight Loss Results
1 articles · Updated · Rio Grande Guardian · Jun 15
Summary
Semaglutide and Tirzepatide can drive major obesity-related weight loss, but Dr. Roque M. Mifugi said treatment should also aim to preserve muscle, strength and physical function.
Clinical trials showed nearly 15% weight loss over 68 weeks with semaglutide and about 15% to 21% with tirzepatide, with a later head-to-head study finding greater average loss with tirzepatide.
To limit lean-mass loss that often accompanies substantial weight reduction, he recommends pairing GLP-1 drugs with individualized higher protein intake and resistance training two to three times a week.
The broader message is that obesity care should be managed as a long-term chronic condition, combining nutrition, exercise, medication when appropriate and ongoing medical support.
Will new drugs that preserve muscle make exercise for weight loss obsolete?
Could a genetic test soon tell you if a weight-loss drug will work and what side effects you might have?
With Medicare’s new temporary coverage, what is the real plan for affording these revolutionary weight-loss drugs after 2027?
GLP-1 Medications and Muscle Loss: The Critical Role of Lifestyle Interventions for Long-Term Success
Overview
This report highlights how the success of GLP-1 receptor agonists (GLP-1 RAs) in weight loss and diabetes management depends on more than just medication. Experts, including Dr. Mifugi, stress that integrating lifestyle strategies—especially resistance training and adequate protein intake—is essential for long-term health. New research shows that while GLP-1s help reduce fat, they can also lead to some muscle loss, making it important to combine these drugs with healthy habits. The report emphasizes that GLP-1s are a helpful tool, but lasting results require ongoing effort and a holistic approach.